Images | Sources | Experiment + Assay | Phenotypes | Human Diseases | ||||
---|---|---|---|---|---|---|---|---|
![]() |
Fig. 5 e f
Harata A et al. (2019) |
Xla Wt + p2ry4
NF9 (in situ hybridization) |
|
|||||
![]() |
Fig. 5 h i
Harata A et al. (2019) |
Xla Wt + p2ry4
NF9 (in situ hybridization) |
|
|||||
![]() |
Fig. 4 f
Harata A et al. (2019) |
Xla Wt + p2ry4 TALEN
NF11 (in situ hybridization) |
|
|||||
![]() |
Fig. 4 l
Harata A et al. (2019) |
Xla Wt + p2ry4 TALEN
NF11 (in situ hybridization) |
|
|||||
![]() |
Fig. 2 c
Harata A et al. (2019) |
Xla Wt + p2ry4 TALEN
NF13 (in situ hybridization) |
|
|||||
![]() |
Fig. 2 i
Harata A et al. (2019) |
Xla Wt + p2ry4 TALEN
NF14 (in situ hybridization) |
|
|||||
![]() |
Fig. 3 c f
Harata A et al. (2019) |
Xla Wt + p2ry4 TALEN
NF14 (in situ hybridization) |
|
|||||
![]() |
Fig. 3 i
Harata A et al. (2019) |
Xla Wt + p2ry4 TALEN
NF14 (in situ hybridization) |
|
|||||
![]() |
Fig. 3 l
Harata A et al. (2019) |
Xla Wt + p2ry4 TALEN
NF14 (in situ hybridization) |
|
|||||
![]() |
Fig. 3 o
Harata A et al. (2019) |
Xla Wt + p2ry4 TALEN
NF14 (in situ hybridization) |
|